NCT05519774

Brief Summary

The Inova research team will ask people who have had an experience of breast cancer and related changes to their cognition to complete some scales that researchers have established describe brain fog (called patient reported outcomes) and compare those results to the TOSL results. This will be done twice to see if changes are detected similarly on both types of measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2022

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

August 11, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 29, 2022

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 18, 2024

Completed
Last Updated

March 7, 2025

Status Verified

March 1, 2025

Enrollment Period

1.9 years

First QC Date

August 11, 2022

Last Update Submit

March 6, 2025

Conditions

Keywords

Breast cancer

Outcome Measures

Primary Outcomes (2)

  • Number of months to recruit

    Number of months between opening of recruitment and recruitment date of the 10th subject.

    4 months

  • Correlation between the TOSL score and PAOFI score

    Spearman correlation coefficient between the TOSL Lessons score and the PAOFI higher level cognition subscale score.

    6 months

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Men or women with stage I-III breast cancer.

You may qualify if:

  • years of age or older
  • ECOG performance status ≤ 2
  • Patients diagnosed or with a history of breast cancer within the last 5 years.
  • Life expectancy of at least 3 months
  • Subject reports experiencing brain fog or cognitive impairment that the subject attributes to cancer or cancer therapy
  • Able to sit for one hour and attend and respond to verbal and written instructions.
  • Able to use a computer

You may not qualify if:

  • Brain metastases from breast cancer
  • Severe hearing or visual impairment
  • Unable to give informed consent
  • Unable to read and write in English
  • Those diagnosed with history of neurologic injuries or disorders (e.g. seizures, strokes, traumatic brain injury, brain surgery, neurodegenerative disorders) other than those attributable to cancer or cancer therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Inova HCS

Falls Church, Virginia, 22042, United States

Location

MeSH Terms

Conditions

Mental FatigueBreast Neoplasms

Condition Hierarchy (Ancestors)

FatigueSigns and SymptomsPathological Conditions, Signs and SymptomsBehavioral SymptomsBehaviorNeoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Adam Cohen, MD

    Inova Health Care Services

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2022

First Posted

August 29, 2022

Study Start

August 1, 2022

Primary Completion

June 18, 2024

Study Completion

October 18, 2024

Last Updated

March 7, 2025

Record last verified: 2025-03

Locations